FDA Inspection 1248255 — Syrinx Bioanalytics Oy
The FDA completed an inspection of Syrinx Bioanalytics Oy on Aug 9, 2024 in Turku. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 9, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Turku (Finland)
Additional Details
Bioanalytical BA/BE